Immunotherapy for cancer is a fast growing research area, and new developments are announced regularly. For example, in January 2023 alone, a [personalised cancer immunotherapy has been granted an FDA fast-track designation.](https://www.europeanpharmaceuticalreview.com/news/178798/personalised-cancer-immunotherapy-granted-fast-track-designation/) Also, research has revealed that [immunotherapy prior to surgery can be remarkably effective for colorectal cancer](https://www.news-medical.net/news/20230112/Immunotherapy-prior-to-surgery-strikingly-effective-for-patients-with-colorectal-cancer.aspx) patients. More developments like these will lead to more research, which in turn will result in more data requiring bioinformatic analysis.